TPA in the injured central nervous system: Different scenarios starring the same actor?

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 749-756

  Lemarchant, Sighild ^a   Docagne, Fabian ^a   Emery, Evelyne ^a   Vivien, Denis ^a   Ali, Carine ^a   Rubio, Marina ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Multiple sclerosis; Spinal cord injury; Stroke; Tissue plasminogen activator

Indexed keywords

GELATINASE B; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; STROMELYSIN; TISSUE PLASMINOGEN ACTIVATOR;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; CELL FATE; DEMYELINATION; ENCEPHALITIS; ENDOTHELIUM CELL; EXCITOTOXICITY; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HUMAN; INTRACELLULAR SIGNALING; MACROPHAGE MIGRATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL GROWTH; NERVE FIBER DEGENERATION; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

EID: 84855921310     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.10.020     Document Type: Review

References (85)

1. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol. Dis. 37 2010 13 25
2. Y. Abe, H. Nakamura, O. Yoshino, T. Oya, and T. Kimura Decreased neural damage after spinal cord injury in tPA-deficient mice J. Neurotrauma 20 2003 43 57
3. R.M. Adibhatla, and J.F. Hatcher Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies CNS Neurol. Disord. Drug Targets 7 2008 243 253
4. K. Akassoglou, K.W. Kombrinck, J.L. Degen, and S. Strickland Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury J. Cell Biol. 149 2000 1157 1166
5. J. An, C. Zhang, R. Polavarapu, X. Zhang, X. Zhang, and M. Yepes Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain Blood 112 2008 2787 2794
6. T. Aoki, T. Sumii, T. Mori, X. Wang, and E.H. Lo Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats Stroke 33 2002 2711 2717
7. A. Baron, A. Montagne, F. Cassé, S. Launay, E. Maubert, C. Ali, and D. Vivien NR2D containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity Cell Death Differ. 17 2010 860 871
8. A. Baron, Y. Hommet, F. Cassé, and D. Vivien Tissue-type plasminogen activator induces plasmin-dependent proteolysis of intracellular neuronal nitric oxide synthase Biol. Cell. 102 2010 539 547
9. E.E. Benarroch Tissue plasminogen activator: beyond thrombolysis Neurology 69 2007 799 802
10. K. Benchenane, H. Castel, M. Boulouard, R. Bluthé, M. Fernandez-Monreal, B.D. Roussel, J.P. Lopez-Atalaya, S. Butt-Gueulle, V. Agin, E. Maubert, R. Dantzer, O. Touzani, F. Dauphin, D. Vivien, and C. Ali Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory J. Cell Sci. 120 2007 578 585
11. W. Cammer, B.R. Bloom, W.T. Norton, and S. Gordon Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination Proc. Natl. Acad. Sci. USA 75 1978 1554 1558
12. Z.L. Chen, and S. Strickland Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin Cell 91 1997 917 925
13. L. Claudio, C.S. Raine, and C.F. Brosnan Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis Acta Neuropathol. 90 1995 228 238
14. F. Correa, M. Gauberti, J. Parcq, R. Macrez, Y. Hommet, P. Obiang, M. Hernangómez, A. Montagne, G. Liot, C. Guaza, E. Maubert, C. Ali, D. Vivien, and F. Docagne Tissue plasminogen activator prevents white matter damage following stroke J. Exp. Med. 208 2011 1229 1242
15. E. Cuadrado, L. Ortega, M. Hernández-Guillamon, A. Penalba, I. Fernández-Cadenas, A. Rosell, and J. Montaner Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release J. Leukoc. Biol. 84 2008 207 214
16. L.A. Cunningham, M. Wetzel, and G.A. Rosenberg Multiple roles for MMPs and TIMPs in cerebral ischemia Glia 50 2005 329 339
17. G.J. del Zoppo, and T. Mabuchi Cerebral microvessel responses to focal ischemia J. Cereb. Blood Flow Metab. 23 2003 879 894
18. F. Docagne, V. Muñetón, D. Clemente, C. Ali, F. Loría, F. Correa, M. Hernangómez, L. Mestre, D. Vivien, and C. Guaza Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation Mol. Cell. Neurosci. 34 2007 551 561
19. F. Docagne, O. Nicole, H.H. Marti, E.T. MacKenzie, A. Buisson, and D. Vivien Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia FASEB J. 13 1999 1315 1324
20. E. East, D. Baker, G. Pryce, H.R. Lijnen, M.L. Cuzner, and D. Gverić A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis Am. J. Pathol. 167 2005 545 554
21. E. East, D. Gverić, D. Baker, G. Pryce, H.R. Lijnen, and M.L. Cuzner Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation Neuropathol. Appl. Neurobiol. 34 2008 216 230
22. R. Echeverry, J. Wu, W.B. Haile, J. Guzman, and M. Yepes Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus J. Clin. Invest. 120 2010 2194 2205
23. M. Fernández-Monreal, J.P. López-Atalaya, K. Benchenane, M. Cacquevel, F. Dulin, J.P. Le Caer, J. Rossier, A.C. Jarrige, E.T. Mackenzie, N. Colloc'h, C. Ali, and D. Vivien Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling J. Biol. Chem. 279 2004 50850 50856
24. M. Fernández-Monreal, J.P. López-Atalaya, K. Benchenane, F. Léveillé, M. Cacquevel, L. Plawinski, E.T. MacKenzie, G. Bu, A. Buisson, and D. Vivien Is tissue-type plasminogen activator a neuromodulator? Mol. Cell. Neurosci. 25 2004 594 601
25. M.T. Fitch, and J. Silver CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure Exp. Neurol. 209 2008 294 301
26. M.P. Flavin, G. Zhao, and L.T. Ho Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro Glia 29 2000 347 354
27. S. Fukuda, C.A. Fini, T. Mabuchi, J.A. Koziol, L.L. Eggleston Jr., and G.J. del Zoppo Focal cerebral ischemia induces active proteases that degrade microvascular matrix Stroke 35 2004 998 1004
28. K. Gijbels, P. Proost, S. Masure, H. Carton, A. Billiau, and G. Opdenakker Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein J. Neurosci. Res. 36 1993 432 440
29. D. Gveric, R. Hanemaaijer, J. Newcombe, N.A. van Lent, C.F. Sier, and M.L. Cuzner Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage Brain 124 2001 1978 1988
30. D. Gveric, B. Herrera, A. Petzold, D.A. Lawrence, and M.L. Cuzner Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors Brain 126 2003 1590 1598
31. W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Dávalos, D. Guidetti, V. Larrue, K.R. Lees, Z. Medeghri, T. Machnig, D. Schneider, R. von Kummer, N. Wahlgren, D. Toni, and ECASS Investigators Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N. Engl. J. Med. 359 2008 1317 1329
32. R. Jin, G. Yang, and G. Li Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator Neurobiol. Dis. 38 2010 376 385
33. C.S. Kidwell, L. Latour, J.L. Saver, J.R. Alger, S. Starkman, G. Duckwiler, R. Jahan, F. Vinuela UCLA Thrombolysis Investigators D.W. Kang, and S. Warach Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke Cerebrovasc. Dis. 25 2008 338 343
34. Y.H. Kim, J.H. Park, S.H. Hong, and J.Y. Koh Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator Science 284 1999 647 650
35. T. Kozai, H. Yamanaka, Y. Dai, K. Obata, K. Kobayashi, T. Mashimo, and K. Noguchi Tissue type plasminogen activator induced in rat dorsal horn astrocytes contributes to mechanical hypersensitivity following dorsal root injury Glia 55 2007 595 603
36. M. Kvajo, H. Albrecht, M. Meins, U. Hengst, E. Troncoso, S. Lefort, J.Z. Kiss, C.C. Petersen, and D. Monard Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors J. Neurosci. 24 2004 9734 9743
37. C.Z. Lee, Z. Xue, Y. Zhu, G.Y. Yang, and W.L. Young Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage Stroke 38 2007 2563 2568
38. H.Y. Lee, I.Y. Hwang, H. Im, J.Y. Koh, and Y.H. Kim Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons J. Neurochem. 101 2007 1236 1247
39. M.L. Lemons, D.R. Howland, and D.K. Anderson Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation Exp. Neurol. 160 1999 51 65
40. E.G. Levin, L. Santell, and K.G. Osborn The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location J. Cell Sci. 110 1997 139 148
41. C. Ling, T. Zou, Y. Hsiao, X. Tao, Z.L. Chen, S. Strickland, and H. Song Disruption of tissue plasminogen activator gene reduces macrophage migration Biochem. Biophys. Res. Commun. 349 2006 906 912
42. G. Liot, B.D. Roussel, N. Lebeurrier, K. Benchenane, J.P. López-Atalaya, D. Vivien, and C. Ali Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity J. Neurochem. 98 2006 1458 1464
43. D. Liu, T. Cheng, H. Guo, J.A. Fernández, J.H. Griffin, X. Song, and B.V. Zlokovic Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C Nat. Med. 10 2004 1379 1383
44. W. Lu, M. Bhasin, and S.E. Tsirka Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis J. Neurosci. 22 2002 10781 10789
45. R. Macrez, M. Gauberti, D. Vivien, and C. Ali New Thrombolytic Agents, in Tratamiento del ictus isquemico 2009 Marge Medica Books Barcelona pp. 59-77
46. T. Matys, and S. Strickland Tissue plasminogen activator and NMDA receptor cleavage Nat. Med. 9 2003 371 372
47. M.G. Medina, M.D. Ledesma, J.E. Domínguez, M. Medina, D. Zafra, F. Alameda, C.G. Dotti, and P. Navarro Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation EMBO J. 24 2005 1706 1716
48. K. Minor, J. Phillips, and N.W. Seeds Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury J. Neurochem. 109 2009 706 715
49. K.H. Minor, and N.W. Seeds Plasminogen activator induction facilitates recovery of respiratory function following spinal cord injury Mol. Cell. Neurosci. 37 2008 143 152
50. E. Miranda, and D.A. Lomas Neuroserpin: a serpin to think about Cell. Mol. Life Sci. 63 2006 709 722
51. O. Nicole, F. Docagne, C. Ali, I. Margaill, P. Carmeliet, E.T. MacKenzie, D. Vivien, and A. Buisson The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
52. W.B. Nolin, J. Emmetsberger, N. Bukhari, Y. Zhang, J.M. Levine, and S.E. Tsirka tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2 Glia 56 2008 177 189
53. P.T. Pang, H.K. Teng, E. Zaitsev, N.T. Woo, K. Sakata, S. Zhen, K.K. Teng, W.H. Yung, B.L. Hempstead, and B. Lu Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity Science 306 2004 487 491
54. S.R. Parathath, S. Parathath, and S.E. Tsirka Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice J. Cell. Sci. 119 2006 339 349
55. L. Park, E.F. Gallo, J. Anrather, G. Wang, E.H. Norris, J. Paul, S. Strickland, and C. Iadecola Key role of tissue plasminogen activator in neurovascular coupling Proc. Natl. Acad. Sci. USA 105 2008 1073 1078
56. D. Pennica, W.E. Holmes, W.J. Kohr, R.N. Harkins, G.A. Vehar, C.A. Ward, W.F. Bennett, E. Yelverton, P.H. Seeburg, H.L. Heyneker, D.V. Goeddel, and D. Collen Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli Nature 301 1983 214 221
57. D. Pitt, P. Werner, and C.S. Raine Glutamate excitotoxicity in a model of multiple sclerosis Nat. Med. 6 2000 67 70
58. R. Polavarapu, J. An, C. Zhang, and M. Yepes Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death Am. J. Pathol. 172 2008 1355 1362
59. C. Profyris, S.S. Cheema, D. Zang, M.F. Azari, K. Boyle, and S. Petratos Degenerative and regenerative mechanisms governing spinal cord injury Neurobiol. Dis. 15 2004 415 436
60. A. Reijerkerk, G. Kooij, S.M. van der Pol, T. Leyen, K. Lakeman, B. van Het Hof, D. Vivien, and H.E. de Vries The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier J. Neurochem. 113 2010 447 453
61. A. Reijerkerk, G. Kooij, S.M. van der Pol, T. Leyen, B. van Het Hof, P.O. Couraud, D. Vivien, C.D. Dijkstra, and H.E. de Vries Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier J. Immunol. 181 2008 3567 3574
62. D.C. Rijken Relationships between structure and function of tissue-type plasminogen activator Klin. Wochenschr. 66 1988 33 39
63. A.D. Rogove, C. Siao, B. Keyt, S. Strickland, and S.E. Tsirka Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system J. Cell Sci. 112 1999 4007 4016
64. F.J. Salles, and S. Strickland Localization and regulation of the tissue plasminogen activator plasmin system in the hippocampus J. Neurosci. 22 2002 2125 2134
65. A.L. Samson, and R.L. Medcalf Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity Neuron 50 2006 673 678
66. A.L. Samson, S.T. Nevin, D. Croucher, B. Niego, P.B. Daniel, T.W. Weiss, E. Moreno, D. Monard, D.A. Lawrence, and R.L. Medcalf Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function J. Neurochem. 107 2008 1091 1101
67. A.P. Sappino, R. Madani, J. Huarte, D. Belin, J.Z. Kiss, A. Wohlwend, and J.D. Vassalli Extracellular proteolysis in the adult murine brain J. Clin. Invest. 92 1993 679 685
68. N.W. Seeds, L.B. Siconolfi, and S.P. Haffke Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding Cell Tissue Res. 290 1997 367 370
69. J.J. Sheehan, C. Zhou, I. Gravanis, A.D. Rogove, Y.P. Wu, D.F. Bogenhagen, and S.E. Tsirka Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies, excitotoxic neurodegeneration in mice J. Neurosci. 27 2007 1738 1745
70. C.J. Siao, S.R. Fernandez, and S.E. Tsirka Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury J. Neurosci. 23 2003 3234 3242
71. C.J. Siao, and S.E. Tsirka Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II J. Neurosci. 22 2002 3352 3358
72. E.J. Su, L. Fredriksson, M. Geyer, E. Folestad, J. Cale, J. Andrae, Y. Gao, K. Pietras, K. Mann, M. Yepes, D.K. Strickland, C. Betsholtz, U. Eriksson, and D.A. Lawrence Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke Nat. Med. 14 2008 731 737
73. Y. Suzuki, N. Nagai, K. Umemura, D. Collen, and H.R. Lijnen Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice J. Thromb. Haemost. 5 2007 1732 1739
74. P. Tanswell, E. Seifried, E. Stang, and J. Krause Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator Arzneimittelforschung 41 1991 1310 1319
75. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N. Engl. J. Med. 333 1995 1581 1587
76. S.E. Tsirka, A. Gualandris, D.G. Amaral, and S. Strickland Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator Nature 377 1995 340 344
77. M.E. van den Berg, J.M. Castellote, I. Mahillo-Fernandez, and J. de Pedro-Cuesta Incidence of spinal cord injury worldwide: a systematic review Neuroepidemiology 34 2010 184 192
78. K.K. Veeravalli, V.R. Dasari, A.J. Tsung, D.H. Dinh, M. Gujrati, D. Fassett, and J.S. Rao Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury Neurochem. Res. 34 2009 1183 1194
79. L.L. Yeo, J.S. Lim, and V.K. Sharma Spinal epidural hematoma after intravenous thrombolysis for acute ischemic stroke J. Neurol. Sci. 284 2009 190 191
80. M. Yepes, B.D. Roussel, C. Ali, and D. Vivien Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic Trends Neurosci. 32 2009 48 55
81. M. Yepes, M. Sandkvist, E.G. Moore, T.H. Bugge, D.K. Strickland, and D.A. Lawrence Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein J. Clin. Invest. 112 2003 1533 1540
82. M. Yepes, M. Sandkvist, M.K. Wong, T.A. Coleman, E. Smith, S.L. Cohan, and D.A. Lawrence Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis Blood 96 2000 569 576
83. C. Zhang, J. An, W.B. Haile, R. Echeverry, D.K. Strickland, and M. Yepes Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain J. Cereb. Blood Flow Metab. 29 2009 1946 1954
84. X. Zhang, R. Polavarapu, H. She, Z. Mao, and M. Yepes Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation Am. J. Pathol. 171 2007 1281 1290
85. B.V. Zlokovic, L. Wang, N. Sun, S. Haffke, S. Verrall, N.W. Seeds, M.J. Fisher, and S.S. Schreiber Expression of tissue plasminogen activator in cerebral capillaries: possible fibrinolytic function of the blood-brain barrier Neurosurgery 37 1995 955 961